ENvue Medical NAOV Stock
ENvue Medical Price Chart
ENvue Medical NAOV Financial and Trading Overview
| ENvue Medical stock price | 4.02 USD |
| Previous Close | 3.39 USD |
| Open | 3.5 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1200 |
| Day's Range | 3.35 - 3.74 USD |
| 52 Week Range | 2.94 - 15.4 USD |
| Volume | 7.84K USD |
| Avg. Volume | 10.52K USD |
| Market Cap | 6.06M USD |
| Beta (5Y Monthly) | 0.901408 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -51.81 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NAOV Valuation Measures
| Enterprise Value | 4.18M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.4974074 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.2610335 |
| Price/Book (mrq) | 2.7493584 |
| Enterprise Value/Revenue | 5.01 |
| Enterprise Value/EBITDA | -0.89 |
Trading Information
ENvue Medical Stock Price History
| Beta (5Y Monthly) | 0.901408 |
| 52-Week Change | -66.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.4 USD |
| 52 Week Low | 2.94 USD |
| 50-Day Moving Average | 3.55 USD |
| 200-Day Moving Average | 5.89 USD |
NAOV Share Statistics
| Avg. Volume (3 month) | 10.52K USD |
| Avg. Daily Volume (10-Days) | 5.7K USD |
| Shares Outstanding | 1.66M |
| Float | 1.65M |
| Short Ratio | 2.95 |
| % Held by Insiders | 0.62% |
| % Held by Institutions | 7.11% |
| Shares Short | 36.5K |
| Short % of Float | 2.20% |
| Short % of Shares Outstanding | 2.19% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -563.32% |
| Gross Margin | 35.49% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -47.079% |
| Return on Equity (ttm) | -145.043% |
Income Statement
| Revenue (ttm) | 834K USD |
| Revenue Per Share (ttm) | 0.56 USD |
| Quarterly Revenue Growth (yoy) | 30.09% |
| Gross Profit (ttm) | 167K USD |
| EBITDA | -4696592 USD |
| Net Income Avi to Common (ttm) | -5413000 USD |
| Diluted EPS (ttm) | -3.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.51M USD |
| Total Cash Per Share (mrq) | 0.91 USD |
| Total Debt (mrq) | 55K USD |
| Total Debt/Equity (mrq) | 2.5 USD |
| Current Ratio (mrq) | 1.994 |
| Book Value Per Share (mrq) | 1.325 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6494000 USD |
| Levered Free Cash Flow (ttm) | -4035933 USD |
Profile of ENvue Medical
| Country | United States |
| State | NY |
| City | Elmsford |
| Address | 525 Executive Boulevard |
| ZIP | 10523 |
| Phone | 914-233-3004 |
| Website | https://www.nanovibronix.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Q&A For ENvue Medical Stock
What is a current NAOV stock price?
ENvue Medical NAOV stock price today per share is 4.02 USD.
How to purchase ENvue Medical stock?
You can buy NAOV shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ENvue Medical?
The stock symbol or ticker of ENvue Medical is NAOV.
Which industry does the ENvue Medical company belong to?
The ENvue Medical industry is Medical Devices.
How many shares does ENvue Medical have in circulation?
The max supply of ENvue Medical shares is 1.09M.
What is ENvue Medical Price to Earnings Ratio (PE Ratio)?
ENvue Medical PE Ratio is now.
What was ENvue Medical earnings per share over the trailing 12 months (TTM)?
ENvue Medical EPS is -51.81 USD over the trailing 12 months.
Which sector does the ENvue Medical company belong to?
The ENvue Medical sector is Healthcare.
ENvue Medical NAOV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23651.32 USD — |
+0.16
|
630.48M USD — | 23610.19 USD — | 23663.6 USD — | — - | 630.48M USD — |
| US Tech Capital Market Composite RCMP | 131.29 USD — |
-1.33
|
— — | 131.24 USD — | 132.71 USD — | — - | — — |
| US Tech Health Care IXHC | 1208.21 USD — |
-0.32
|
— — | 1207.76 USD — | 1210.54 USD — | — - | — — |
- {{ link.label }} {{link}}